Comparison of All-Cause Mortality Rate and Economic Burden Between Newly Diagnosed Alzheimer’s Disease Patients Who Received Anti-Dementia Treatment Versus Not: a Longitudinal Retrospective Study

Black, CMHu, XKhandker RKAmbegaonkar, BMKariburyo, M. FurahaXie, LBaşer, OnurYuce, H.2019-02-282019-02-282019-02-282019-02-282016Black C.M, Hu X, Khandker RK, Ambegaonkar BM, Kariburyo MF, Xie L, Baser O, Yuce H. (July 24-28, 2016). Comparison of all-cause mortality rate and economic burden between newly diagnosed Alzheimer’s disease patients who received anti-dementia treatment versus not: A longitudinal retrospective study. Alzheimer's Association International Conference (AAIC) Annual Conference. Toronto, Canada.https://hdl.handle.net/20.500.11779/819Onur Başer (MEF Author)##nofulltext##...eninfo:eu-repo/semantics/closedAccessComparison of All-Cause Mortality Rate and Economic Burden Between Newly Diagnosed Alzheimer’s Disease Patients Who Received Anti-Dementia Treatment Versus Not: a Longitudinal Retrospective StudyConference Object